These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15878752)

  • 1. Immunohistochemical expression of RANK, GRalpha and CTR in central giant cell granuloma of the jaws.
    Tobón-Arroyave SI; Franco-González LM; Isaza-Guzmán DM; Floréz-Moreno GA; Bravo-Vásquez T; Castañeda-Peláez DA; Vieco-Durán B
    Oral Oncol; 2005 May; 41(5):480-8. PubMed ID: 15878752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical expression of glucocorticoid and calcitonin receptors as a tool for selecting therapeutic approach in central giant cell granuloma of the jawbones.
    Vered M; Buchner A; Dayan D
    Int J Oral Maxillofac Surg; 2006 Aug; 35(8):756-60. PubMed ID: 16580179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parathyroid hormone-related peptide (PTHrP), parathyroid hormone/parathyroid hormone-related peptide receptor 1 (PTHR1), and MSX1 protein are expressed in central and peripheral giant cell granulomas of the jaws.
    Houpis CH; Tosios KI; Papavasileiou D; Christopoulos PG; Koutlas IG; Sklavounou A; Alexandridis C
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):415-24. PubMed ID: 20060342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcitonin nasal spray for treatment of central giant cell granuloma: clinical, radiological, and histological findings and immunohistochemical expression of calcitonin and glucocorticoid receptors.
    Vered M; Shohat I; Buchner A; Dayan D; Taicher S
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Aug; 104(2):226-39. PubMed ID: 17630098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue.
    Lau YS; Sabokbar A; Gibbons CL; Giele H; Athanasou N
    Hum Pathol; 2005 Sep; 36(9):945-54. PubMed ID: 16153456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoexpression of calcitonin and glucocorticoid receptors in central giant cell lesions of the jaws.
    Batista Severo ML; Lopes MLDS; Miguel MCDC; Germano AR; Nogueira RLM; Turatti E; Cavalcante RB; da Silveira ÉJD
    J Oral Pathol Med; 2018 Oct; 47(9):907-913. PubMed ID: 30028524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomorphometric and immunohistochemical comparison between central and peripheral giant cell lesions of the jaws.
    Flórez-Moreno GA; Henao-Ruiz M; Santa-Sáenz DM; Castañeda-Peláez DA; Tobón-Arroyave SI
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 May; 105(5):625-32. PubMed ID: 18299236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoid and calcitonin receptor expression in central giant cell lesions: implications for therapy.
    Nogueira RL; Faria MH; Osterne RL; Cavalcante RB; Ribeiro RA; Rabenhorst SH
    Int J Oral Maxillofac Surg; 2012 Aug; 41(8):994-1000. PubMed ID: 22365107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RANKL protein is expressed at the pannus-bone interface at sites of articular bone erosion in rheumatoid arthritis.
    Pettit AR; Walsh NC; Manning C; Goldring SR; Gravallese EM
    Rheumatology (Oxford); 2006 Sep; 45(9):1068-76. PubMed ID: 16490750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Central giant cell lesions of the jaws: a clinicopathological study of 31 cases].
    Liu B; Yu SF; Wu YT; Pang SZ
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Jan; 40(1):67-9. PubMed ID: 15774157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical expression of alpha-smooth muscle actin and glucocorticoid and calcitonin receptors in central giant-cell lesions.
    Maiz NN; de la Rosa-García E; Camacho ME
    J Oral Pathol Med; 2016 Apr; 45(4):289-94. PubMed ID: 26467443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of bone-regulatory proteins in human valve allografts.
    Shetty R; Pepin A; Charest A; Perron J; Doyle D; Voisine P; Dagenais F; Pibarot P; Mathieu P
    Heart; 2006 Sep; 92(9):1303-8. PubMed ID: 16449517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoexpression of NF-ĸB and their inhibitory subunits IĸBα and IĸBβ in giant cell lesions of the jaws: implications for their clinical behavior.
    Tobón-Arroyave SI; Hurtado-García P; García-Quintero OD; Isaza-Guzmán DM; Flórez-Moreno GA
    J Oral Pathol Med; 2015 Oct; 44(9):752-60. PubMed ID: 25413222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoids, calcitonin, and osteocalcin cannot differentiate between aggressive and nonaggressive central giant cell lesions of the jaws.
    Martins AF; Souza PO; Rege IC; Morais MO; Mendonça EF
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Sep; 120(3):386-95. PubMed ID: 26188731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hematopoietic transcription factor PU.1 regulates RANK gene expression in myeloid progenitors.
    Kwon OH; Lee CK; Lee YI; Paik SG; Lee HJ
    Biochem Biophys Res Commun; 2005 Sep; 335(2):437-46. PubMed ID: 16083856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoclast differentiation and bone resorption in multicentric reticulohistiocytosis.
    Adamopoulos IE; Wordsworth PB; Edwards JR; Ferguson DJ; Athanasou NA
    Hum Pathol; 2006 Sep; 37(9):1176-85. PubMed ID: 16938523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implant wear induces inflammation, but not osteoclastic bone resorption, in RANK(-/-) mice.
    Ren W; Wu B; Peng X; Hua J; Hao HN; Wooley PH
    J Orthop Res; 2006 Aug; 24(8):1575-86. PubMed ID: 16779834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of receptor activator of NF-kappa B ligand and osteoprotegerin protein in the giant cell lesions of jaw].
    Meng XM; Yu SF; Wei MJ
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Jul; 40(4):294-7. PubMed ID: 16191370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RANK ligand expression in heat shock factor-2 deficient mouse bone marrow stromal/preosteoblast cells.
    Kajiya H; Ito M; Ohshima H; Kenmotsu S; Ries WL; Benjamin IJ; Reddy SV
    J Cell Biochem; 2006 Apr; 97(6):1362-9. PubMed ID: 16365894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant B-lymphoid cells with bone lesions express receptor activator of nuclear factor-kappaB ligand and vascular endothelial growth factor to enhance osteoclastogenesis.
    Shibata H; Abe M; Hiura K; Wilde J; Moriyama K; Sano T; Kitazoe K; Hashimoto T; Ozaki S; Wakatsuki S; Kido S; Inoue D; Matsumoto T
    Clin Cancer Res; 2005 Sep; 11(17):6109-15. PubMed ID: 16144909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.